# GammaTile and Stupp in Newly Diagnosed GBM

> **NCT05342883** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **GT Medical Technologies, Inc.** · enrollment: 61 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

## Key facts

- **NCT ID:** NCT05342883
- **Lead sponsor:** GT Medical Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-17
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 61 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05342883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05342883, "GammaTile and Stupp in Newly Diagnosed GBM". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05342883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*